Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
McKinsey
AstraZeneca
Express Scripts
Boehringer Ingelheim

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

TROSPIUM CHLORIDE Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Trospium Chloride, and when can generic versions of Trospium Chloride launch?

Trospium Chloride is a drug marketed by Actavis Labs Fl Inc, Paddock Llc, Upsher Smith Labs, Apotex, Glenmark Generics, Heritage Pharms Inc, and Invagen Pharms. and is included in eight NDAs.

The generic ingredient in TROSPIUM CHLORIDE is trospium chloride. There are sixteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the trospium chloride profile page.

Drug patent expirations by year for TROSPIUM CHLORIDE
Drug Prices for TROSPIUM CHLORIDE

See drug prices for TROSPIUM CHLORIDE

Recent Clinical Trials for TROSPIUM CHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Amiri HospitalN/A
Mansoura UniversityN/A
Karuna PharmaceuticalsPhase 2

See all TROSPIUM CHLORIDE clinical trials

Recent Litigation for TROSPIUM CHLORIDE

Identify potential future generic entrants

District Court Litigation
Case NameDate
SUPERNUS PHARMACEUTICALS, INC. v. PAR PHARMACEUTICAL COMPANIES, INC.2015-01-16
Allergan Inc. v. Watson Laboratories, Inc.-Florida

See all TROSPIUM CHLORIDE litigation

Pharmacology for TROSPIUM CHLORIDE
Synonyms for TROSPIUM CHLORIDE
(1alpha,5alpha)-3beta-[(Hydroxydiphenylacetyl)oxy]spiro[8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium]
[(1R,5S)-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl] 2-hydroxy-2,2-diphenylacetate chloride
[(1S,5R)-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl] 2-hydroxy-2,2-diphenylacetate;chloride
[(1S,5R)-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl] 2-oxidanyl-2,2-diphenyl-ethanoate chloride
1001323-19-8
10405-02-4
1E6682427E
2-hydroxy-2,2-diphenylacetic acid [(1S,5R)-3-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]yl] ester chloride
3-((hydroxydiphenylacetyl)oxy)-spiro(8-azoniabicyclo(3.2.1)octane-8,1'-pyrrolidinium chloride
3alpha-Hydroxyspiro(1alphah,5alphah-nortropane-8,1'-pyrrolidinium) benzilate
3alpha-Hydroxyspiro(1alphaH,5alphaH-nortropane-8,1'-pyrrolidinium) chloride benzilate
405T024
47608-32-2
8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride
A800884
AB0000782
AB01274814_02
AB01274814-01
AB2000646
AC-4235
AC1NR4ST
AKOS015833209
AM84314
API0004533
AS Xvii
Azoniaspiro Compound XVII
Azoniaspiro(3-alpha-benziloyloxy-nortropan-8,1'-pyrrolidine)-chloride
B-1868
BC209629
BCP0726000291
BCP23426
CAS-10405-02-4
CHEBI:32270
CHEMBL1888176
CHEMBL3084748
Chlorure de trospium
Chlorure de trospium [INN-French]
Cloruro de trospio
Cloruro de trospio [INN-Spanish]
CS-2572
DB00209
DSSTox_CID_3724
DSSTox_GSID_23724
DSSTox_RID_77166
DTXSID6048337
DTXSID7023724
EINECS 233-875-4
FT-0636699
HMS3656C16
HY-B0461
IP631
Keptan
MolPort-005-935-494
MolPort-046-033-481
NCGC00167438-01
NCGC00167438-02
Relaspium
RVCSYOQWLPPAOA-QKYUOBHYSA-M
s2549
Sanctura
Sanctura XR
Santura
SCHEMBL119810
SCHEMBL13836646
SCHEMBL2447242
SCHEMBL25785
Spasmex
Spasmo 3
Spasmo-lyt
Spiro (8-azoniabicyclo(3.2.1)octane-8,1'-pyrrolidinium), 3-((hydroxydiphenylacetyl)oxy)-, chloride, (1alpha, 3beta, 5alpha)
Spiro(1-alpha-H,5-alpha-H-nortropane-8,1'-pyrrolidinium), 3-alpha-hydroxy-, chloride, benzilate
Spiro(8-azoniabicyclo(3.2.1)octane-8,1'-pyrrolidinium, 3-((hydroxydiphenylacetyl)oxy)-, chloride, (1alpha,3beta,5alpha)-
Spiro[8azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium], 3-[(hydroxydiphenylacetyl)oxy]-, chloride, (1, 3, 5);Spiro[8azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium], 3-[(hydroxydiphenylacetyl)oxy]-, chloride, (1, 3, 5)
ST24050330
SW219146-1
T4Y8ORK057
Tox21_112442
Tox21_112442_1
Trospii chloridum
Trospii chloridum [INN-Latin]
Trospium
Trospium (chloride)
Trospium cation
Trospium chloride (Sanctura)
Trospium chloride [USAN:USP:INN:BAN:JAN]
Trospium Cl
Trospiumchlorid
UNII-1E6682427E
UNII-T4Y8ORK057
Uraplex
W-108827
ZINC100016084
ZINC100371992
ZINC12503068
Paragraph IV (Patent) Challenges for TROSPIUM CHLORIDE
Tradename Dosage Ingredient NDA Submissiondate
SANCTURA XR CAPSULE, EXTENDED RELEASE;ORAL trospium chloride 022103 2009-03-02

US Patents and Regulatory Information for TROSPIUM CHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc TROSPIUM CHLORIDE trospium chloride CAPSULE, EXTENDED RELEASE;ORAL 091289-001 Oct 12, 2012 AB RX No Yes   Start Trial   Start Trial   Start Trial
Invagen Pharms TROSPIUM CHLORIDE trospium chloride TABLET;ORAL 091688-001 Aug 23, 2016 AB RX No No   Start Trial   Start Trial   Start Trial
Apotex TROSPIUM CHLORIDE trospium chloride TABLET;ORAL 091513-001 Dec 6, 2011 AB RX No No   Start Trial   Start Trial   Start Trial
Paddock Llc TROSPIUM CHLORIDE trospium chloride TABLET;ORAL 091573-001 Nov 17, 2010 AB RX No No   Start Trial   Start Trial   Start Trial
Paddock Llc TROSPIUM CHLORIDE trospium chloride CAPSULE, EXTENDED RELEASE;ORAL 201291-001 May 24, 2013 AB RX No No   Start Trial   Start Trial   Start Trial
Upsher Smith Labs TROSPIUM CHLORIDE trospium chloride CAPSULE, EXTENDED RELEASE;ORAL 091635-001 Apr 29, 2015 DISCN No No   Start Trial   Start Trial   Start Trial
Heritage Pharms Inc TROSPIUM CHLORIDE trospium chloride TABLET;ORAL 204945-001 Aug 30, 2016 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
McKesson
Harvard Business School
Colorcon
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.